Cell biology; cell culture and expansion; gene editing using lentiviral vectors or CRISPR/Cas9; assessment of genomic stability of stem cells and their differentiation products; animal models for cancer; immune cell biology and function assays; differentiation of pluripotent stem cells into T cells, Natural Killer (NK) cells, macrophages and other immune cell types; Immune cell killing […]
Cartherics is a biotechnology company focused on developing innovative cancer therapies. We have developed CAR-T cells that are derived from the blood of cancer patients that are genetically modified and expanded for their therapy for blood (cutaneous T cell lymphoma) and solid tumours (ovarian and gastric cancers). Our primary focus is now on therapies that […]
We are based in Victoria, Australia.
Cartherics’ mission is the development of novel, “off-the-shelf” (allogeneic) immune cell therapy products for the treatment of cancer.
Stay informed about our latest news and developments
© Copyright 2022 | Cartherics Pty ltd